small molecule

EVEKEO ODT

AMPHETAMINE SULFATE

Loss of exclusivityMarch 2037latest FDA-listed patent expiry
CompanyAzurity PharmaceuticalsView the full company profile on CliffBio

Drug detail

Brand nameEVEKEO ODT
Active ingredientAMPHETAMINE SULFATE
Strength2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formTABLET, ORALLY DISINTEGRATING
RouteORAL
ModalitySmall molecule
FDA approvalApril 2021
Marketing statusDISCN

Listed patents

PatentExpiresType
10441554March 2037product
11160772March 2037product

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

Not found